| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |